En valorisation
MODERATO
To demonstrate the non-inferiority at 96 weeks of a strategy involving a switch to a two-drug regimen consisting of DTG + 3TC or ATV/r + 3TC compared with the WHO-recommended triple-therapy regimen of TDF + 3TC + EFV or DTG …
Project Details
Principal Investigator
Fatou Fadiga
Duration
72 months
Sponsor
ANRS MIE
Objectives
Main Objectives
To demonstrate the non-inferiority at 96 weeks of a strategy involving a switch to a two-drug regimen consisting of DTG + 3TC or ATV/r + 3TC compared with the WHO-recommended triple-therapy regimen of TDF + 3TC + EFV or DTG in patients who have maintained virologic success for at least two years on TDF + XTC + EFV or DTG
Research Team
The research team has not yet been filled in for this project.
Collaborate with us
We are open to partnerships with international research institutions and doctoral students.
Research Request
Estimated response time: 3-5 business days.
Keywords
OPERATIONS RESEARCH
OUR PROJECTS
COHORTE
